What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Activities Vall d'Hebron Talks by VHIR 'From a clinical problem to a clinical trial. The LIF dilemma' Online seminar organized by Dr. Josep Quer within Translational Biomedical Research Master’s Degree’s Module 1, Transversal Skills for Translational Research in Human Pathology. Speaker: Dr. Joan Seoane- Co-Director of the Preclinical and Translational Research Programme, VHIO- He News FUTURO project to improve the sexual and reproductive health of young people in Angola comes to an end Vall d'Hebron has coordinated this initiative that has carried out numerous training and community awareness activities aimed at empowering young people in sexual and reproductive health issues. News An innovative simulator created in Vall d'Hebron helps to train professionals in ECMO Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique. News Over 450 experts attended the 1st Vall d’Hebron International Congress on Communication in Health The conclusions from the 1st International Congress on Health Communication will provide the basis for a Guide to Health Communication, which will be share with the European University Hospital Alliance (EUHA). News Fake news, communication crises and AI as risk and opportunity, for debate at the second day of the congress Practical workshops and the Meet the Expert session, so that attendees could interact directly with some of the speakers, complete the round tables. News The ongoing collaboration between Vall d'Hebron and the Barcelona PID Foundation improves the quality of life of patients with primary immunodeficiencies One of the most important projects of this joint endeavour is the ‘No estic sol’ project for children and adults: a benchmark care model for minority illnesses which, under the leadership of Vall d'Hebron, has already been extended to other centres. News The importance of scientific communication rigor and creating impactful campaigns kick off the 1st International Health Communication Congress More than 400 professionals from the fields of health, communication, and political institutions exchange reflections and experiences. Experts warn about the impact of misinformation and the need for transparent and effective communication Activities 1r Congrés Internacional de Comunicació en Salut El dijous 24 d'octubre i el divendres 25 d'octubre celebrem el 1r Congrés Internacional de Comunicació en Salut, organitzat per Vall d'Hebron amb el suport de l’ News Vall d'Hebron identifies one of the mechanisms that allows HIV control without treatment A study by the Infectious Diseases group at VHIR has found that some people with HIV can uniquely control the virus thanks to a special type of cell in their immune system. Activities Vall d'Hebron Talks by VHIR 'Fine-tuning endoplasmic reticulum stress and autophagy in cancer: Discovery and preclinical/clinical development of ABTL0812' Speaker: Jose Miguel Lizcano De Vega, Head of group Protein kinases in cancer research (VHIR) Summary: I will present the preclinical and clinical development of ABTL0812 (2-hydroxylinoleic acid), a first-in-class anticancer molecule. ABTL0812 selectively kills cancer cells by indu Activities Vall d'Hebron Talks by VHIR 'Tissue engineering unit CRG: stem cells, organoids and crispr/cas9 platform' Speaker: Laura Batlle Morera - Head of Tissue Engineering Facility at CRG Summary: The Tissue Engineering Platform at CRG provides researchers with the latest technologies used in the fields of stem cell biology, stem cell differentiation, organoid formation and induced Activities Curs de medicina traslacional - TMex 2024 Del 22 al 25 d'octubre tindrà lloc el curs de quatre dies per a estudiants de doctorat i postdoctorat on aprendran com fer que la seva recerca biomèdica sigui més significativa. Activities Defensa de Tesi 'Medicina individualitzada i de precisió al laboratori clínic mitjançant l'ús de la cromatografia líquida i l'espectrometria de masses com a eines d'anàlisi' Doctoranda: Yolanda Villena Ortiz, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (VHIR) Directors: Francisco Rodríguez Frías i Joan López Hellín Tutor: Maria Assumpcio Bosch Merino Activities Vall d'Hebron Talks by VHIR 'Cell therapy for fetal repair' Ponent: Marc Oria, Assistant Professor - University of Cincinnati Activities Defensa de Tesi 'Osteomielitis crònica de tíbia posttraumàtica. Estudi microbiològic i protocol quirúrgic en infeccions cròniques amb inestabilitat òssia' Doctoranda: Carla Carbonell i Rosell, Cirurgia reconstructiva de l'aparell locomotor (VHIR) Directors: Pablo Salvador Corona i Pérez-Cardona, Lluís Carrera i Calderer, Nayana Joshi i Jubert Tutora: Nayana Joshi i Jubert Activities Evaluación de proyectos de investigación Biomédica Por el CEIm del Hospital Universitario Vall d'Hebron ACREDITACIÓN Se entregará certificado de asistencia a aquellos participantes que tengan una asistencia del 80% o superior Nº DE PLAZAS 40 PLAZAS PRECIO DE INSCRIPCIÓN Inscripción personal externo - 45 € Inscripción personal campus, estudiantes y Alumni VH (20%): - 25 € Todas l Activities Jornada ‘Càncer de mama i ovari hereditari’ 09:00 – 09:10h OBERTURA DE LA JORNADA. Dr. Eugeni Saigí. Director del Servei d'Oncologia d'Assistència Sanitària Col·legial (ASC). Fundador Membre de la Junta d'AMOH. 09:10 – 09:40h PRESENT I FUTUR DEL CÀNCER DE MAMA I OVARI HEREDITARI. Dra. Judith Balmaña. Mèdic Oncòloga responsable de News Two Vall d'Hebron projects receive the 2024 Gilead Biomedical Research Grants The awarded projects will study the immune response to HIV and the VIGex tool as a biomarker for immunotherapy response. News The use of ECMO at Vall d'Hebron improves the survival of patients with refractory cardiac arrest Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat. Activities 6ª Edició Jornada del Maneig Integral del Dolor Pagination First page « Previous page ‹ … Page 6 Page 7 Current page 8 Page 9 Page 10 … Next page › Last page »
